Sarah W. Ball

Westat (United States) — United States

Social Sciences · Social Sciences

22h-index2.8kcitations70works6.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Vaccine Coverage and Hesitancy(37), SARS-CoV-2 and COVID-19 Research(33), Influenza Virus Research Studies(18), COVID-19 Clinical Research Studies(17), Respiratory viral infections research(15)

Publications70 total

P-1982. Negative Predictive Value of Methods to Identify Underlying Medical Conditions with and without Use of a Lookback Period among Adults with a Healthcare Encounter for Acute Respiratory Illness, September 2023 – August 2024
Open Forum Infectious Diseases·2026Open Access
P-1657. Difference in reactogenicity events between mRNA and Protein-subunit Vaccines: Results from the Booster Epidemiological Evaluation of Health, Illness, and Vaccine Efficacy (BEEHIVE) Study, a U.S. randomized trial of 2023-2024 COVID-19 vaccines (XBB.1.5)
Open Forum Infectious Diseases·2026Open Access
P-1435. Effectiveness of RSV Immunization among Infants in Their First RSV Season in the United States, 2023-2024 and 2024-2025 Seasons
Open Forum Infectious Diseases·2026Open Access
P-1517. Adult Respiratory Syncytial Virus Vaccination Receipt among Adults Testing Negative for RSV – VISION Network, October 1, 2024—March 31, 2025
Open Forum Infectious Diseases·2026Open Access
P-1501. Effectiveness of 2024–2025 seasonal influenza vaccines against influenza–associated hospitalizations among adults — VISION Network
Open Forum Infectious Diseases·2026Open Access
221. Effectiveness of RSV Vaccines in Older Adults in the United States, VISION Network, 2023-2025
Open Forum Infectious Diseases·2026Open Access
Effectiveness of 2023–2024 Coronavirus Disease 2019 (COVID-19) Vaccines in Pregnant Women
Obstetrics and Gynecology·2025
Effectiveness of 2024–2025 COVID-19 Vaccines in Children in the United States — VISION, August 29, 2024–September 2, 2025
MMWR Morbidity and Mortality Weekly Report·2025· 3 citedOpen Access
Effectiveness of 2023–2024 COVID-19 Vaccines in Children in the United States
PEDIATRICS·2025· 1 cited
Real-world effectiveness and non-inferiority evaluation and comparison of mRNA- and protein-based COVID-19 vaccines: a randomized study protocol (BEEHIVE)
2025Open Access
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults
JAMA Network Open·2025· 16 citedOpen Access
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel
Vaccine·2025Open Access
Patterns in Prescribing and Dispensing Influenza Antivirals Among Adults With Influenza Presenting to Urgent Care and Emergency Department Settings: VISION Network, 2023–2024
Clinical Infectious Diseases·2025· 3 citedOpen Access
Influenza-Associated Hospitalization Rates by Underlying Conditions, 2016–2017 to 2019–2020: A Retrospective Cohort Study
The Journal of Infectious Diseases·2025· 1 cited
P-51. Influenza Vaccine Effectiveness in Ambulatory Care Settings among Pregnant Persons in the 2023-2024 Influenza Season
Open Forum Infectious Diseases·2025Open Access
426. Effectiveness of Updated (2023-2024) Monovalent COVID-19 Vaccines – VISION Network, September 2023-March 2024
Open Forum Infectious Diseases·2025Open Access
Influenza Vaccine Effectiveness Against Hospitalizations and Emergency Department or Urgent Care Encounters for Children, Adolescents, and Adults During the 2023–2024 Season, United States
Clinical Infectious Diseases·2024· 13 citedOpen Access
Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18–64 Years: Results and Experience From a Randomized, Double-Blind Trial
Open Forum Infectious Diseases·2024· 8 citedOpen Access
Effectiveness of the Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters in Pregnant Persons Who Were Not Immunocompromised: VISION Network, June 2022–August 2023
Open Forum Infectious Diseases·2024· 3 citedOpen Access
A human centered design approach to define and measure documentation quality using an EHR virtual simulation
PLoS ONE·2024· 3 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Allison L. Naleway(41), Toan C. Ong(36), Stephanie A. Irving(36), Shaun J. Grannis(33), Malini B. DeSilva(33), Karthik Natarajan(31), Kristin Dascomb(31), Manjusha Gaglani(31), Nicola P. Klein(31), Julie Arndorfer(28), Ousseny Zerbo(28), Suchitra Rao(27), Bruce Fireman(26), Brian E. Dixon(25), Anupam B. Kharbanda(25), Ruth Link‐Gelles(24), Kristin Goddard(23), Michelle A. Barron(23), Peter J. Embí(23), Mark W. Tenforde(23)